Mani Latifi

Mani Latifi practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Mani Latifi's NPI, 1548587033, was assigned on April 23, 2010. Mani Latifi graduated from Southern Illinois University School of Medicine in 2010. Mani Latifi holds Ohio license 35.120977.

Mani Latifi's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Mani Latifi's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Mani Latifi is also affiliated with Fairview Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Mani Latifi to 2 more clinical labs, each named with a free account. Mani Latifi's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Mani Latifi practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Mani Latifi's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Mani Latifi is licensed in Ohio.

CMS data shows 1,593 Medicare services from Mani Latifi across 7 procedure codes in 2024, for 887 Medicare patients. Medicare paid $29,102 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 887 Medicare patients who saw Mani Latifi in 2024. The largest group is 65 to 74, with 444 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mani Latifi's median patient age at 63, with 50% women.

In 2024, Mani Latifi wrote 179 Medicare Part D claims for 39 patients. 34% of them were for generic drugs. CMS names the drug for 111 of them, across 5 drugs with 11 or more claims each, at $13,363 in total drug cost. In 2023, CMS named 429 claims across 13 drugs.

Mani Latifi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Mani Latifi, published from 2015 to 2023. 2021 was the busiest year, with 2. The most frequent topics are Critical Care, Asthma and COVID-19. Mani Latifi has published most often in Cleve Clin J Med. Mani Latifi's most frequent co-authors are Abhijit Duggal, MD, MPH, MS, Sudhir Krishnan, MD and Ajit Rajeshwar Moghekar, MBBS.

CMS Open Payments shows 12 general payments to Mani Latifi from 7 drug and device companies from 2016 to 2023. Travel and lodging make up the largest share, 75% of the total. Genentech, Inc. paid the most, $1,284.

Mani Latifi graduated from Southern Illinois University School of Medicine in 2010.